AzTrials
AzTrials

Chronic Stroke PatientsNCT07042152

Wearable Device and Behavioral Support for Enhancing Arm Use After Stroke

A study testing Smartwatch App for Movement Variability, Smartwatch App for Active Time and Motivational Interviewing (Within Subjects) in people with Chronic Stroke Patients, run by University of California, Irvine at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this study is to determine the effectiveness of behavioral support and feedback from a wearable device that senses arm movement in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients Read more about this study

Who is it for?
Ages 18 to 84 years
Conditions the study is for
Chronic Stroke Patients
What is being tested?
Smartwatch App for Movement Variability, Smartwatch App for Active Time and Motivational Interviewing (Within Subjects)
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
32 participants
Where
1 siteUnited States
Study dates
20 Aug 2025to 29 Jan 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 84 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 to 85 years of age
  • Experienced a single or multiple, ischemic or hemorrhagic stroke, with unilateral weakness, over six months previously
  • An ability to score at least 3 blocks on the Box and Block Test. BBT score of the affected arm is at least 5% worse than that present with the unaffected arm.
  • Absence of major depression, as defined by DSM V criteria or a score on the Geriatric Depression Scale < 10.

Who cannot join

  • Any substantial decrease in alertness, language reception, or attention
  • Single or multiple, ischemic or hemorrhagic stroke less than 6 months ago
  • Severe muscle tone at the upper extremity (score ≥ 3 on the Modified Ashworth Spasticity scale)
  • Pregnant or lactating
  • Advanced liver, kidney, cardiac, or pulmonary disease
  • Coexistent major neurological disease
Show all 13Show fewer
  • Coexistent major psychiatric disease
  • Plans to alter any current participation in other rehabilitation therapy in the time period of the study
  • A terminal medical diagnosis consistent with survival < 1 year
  • A history of significant alcohol or drug abuse in the prior 3 years
  • Current enrollment in another study related to stroke or stroke recovery
  • Any other medical contraindication to participation in the study, as evaluated by our team physician.
  • Visual Analog of Pain Scale Score of 7 or greater

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Vicky Chan, DPT contact

9498248423

vchan2@uci.edu

Natanya Gunn, Medical Student contact

natanyag@hs.uci.edu

United States1 site, 1 recruiting
  • University of California Irvine

    Irvine, California, 92697

    Vicky Chan, DPT, 949-824-8423, vchan2@uci.edu

    David Reinkensmeyer, PhD

    Recruiting

Other trials in United States

About this study

Official title: Sensor Enhanced Activity Motivation After Stroke

The goal of this study is to determine the effectiveness of behavioral support and feedback from a wearable device that senses arm movement in improving upper extremity function in a pilot, randomized controlled trial with chronic stroke patients

Read the detailed description

In this randomized controlled trial, the investigators will evaluate two telerehabilitation strategies for increasing arm use at home: a smartwatch app and a psychological intervention. The psychological intervention aims to address ambivalence and enhance motivation, while the smartwatch provides feedback on arm movement variability. The investigators hypothesize that combining the psychological intervention with smartwatch feedback will lead to greater improvements in arm use and upper extremity recovery

Being tested
Smartwatch App for Movement Variability, Smartwatch App for Active Time, Motivational Interviewing (Within Subjects)
Keywords
Sensor, SmartWatch, Stroke Recovery, Stroke Rehabilitation, Motivational Interviewing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smartwatch App for Movement VariabilityOther

    This app measures movement variability in the upper extremity as described in our previous study (doi:10.3390/s24165266).

  • Smartwatch App for Active TimeOther

    The other software we are using measures total active time of the upper extremity.

  • Motivational Interviewing (Within Subjects)Behavioural

    Motivational Interviewing is an established therapeutic technique designed to increase patient adherence to therapy by addressing ambivalence. The motivational Interviewing sessions will include a variety of techniques such as: Open ended questions, Active Listening, Affirmation, Summarization, Questions focused on change talk, and Providing Information.

Study groups in NCT07042152
Study groupRoleWhat they receive
Movement VariabilityExperimentalThe movement variability group will have a smartwatch app that records movement variability. Their movement goal will be centered on increasing their total movement variability as measured by the watch.
Receives: Other: Smartwatch App for Movement Variability; Behavioral: Motivational Interviewing (Within Subjects)
Active Time (Control)Placebo comparatorThis group will only receive active-time feedback (the number of minutes and hours moving the upper extremity). Their goal will focus on increasing their total movement time.
Receives: Other: Smartwatch App for Active Time; Behavioral: Motivational Interviewing (Within Subjects)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Variability Measurement

    The amount of variability for the impaired upper extremity will be quantified by the variety of movements performed.

    Measured: From enrollment to the end of treatment and follow up measurement (9 weeks)

Secondary outcomes (10)
  1. Active Time

    This outcome measures the active time of the impaired upper extremity in minutes and hours.

    Measured: From enrollment to the end of treatment and follow up measurement (9 weeks)

  2. Fugl-Meyer Arm Motor Assessment

    The Fugl-Meyer Arm Motor Assessment measures motor impairment, movement coordination, reflexes, and functional ability of the upper limb in stroke patients, providing a quantitative evaluation of motor recovery based on a standardized scoring system.

    Measured: Initial Visit, First follow up, Second follow up

  3. Box and Blocks Test

    The Box and Blocks Test (BBT) measures manual dexterity, unilateral gross motor function, and upper limb coordination in stroke patients by assessing the number of blocks transferred within a set time, providing an objective indicator of motor recovery and functional hand use.

    Measured: Initial Visit, First follow up, second follow up

  4. Nine Hole Peg Test

    The 9-Hole Peg Test (9HPT) measures fine motor coordination, dexterity, and finger-hand function by assessing the speed at which a participant can place and remove pegs from a board.

    Measured: Initial Visit, First follow up, Second follow up

  5. Motor Activity Log (MAL)

    The Motor Activity Log (MAL) measures the amount and quality of spontaneous arm use in daily activities in stroke patients with hemiparesis, using patient-reported ratings on a structured questionnaire to assess real-world upper limb function.

    Measured: Initial Visit, First follow up, Second follow up

  6. Open Point

    Open Point measures proprioception in patients with impaired upper extremity function due to stroke.

    Cornella-Barba, G., Farrens, A. J., Johnson, C. A., Garcia-Fernandez, L., Chan, V., \& Reinkensmeyer, D. J. (2024). Using a Webcam to Assess Upper Extremity Proprioception: Experimental Validation and Application to Persons Post Stroke. Sensors (Basel, Switzerland), 24(23), 7434. https://doi.org/10.3390/s24237434

    Measured: Initial Visit, First follow up, Second follow up

  7. NIH Stroke Scale

    The NIH Stroke Scale (NIHSS) measures stroke severity by assessing neurological function, including consciousness, motor and sensory abilities, language, vision, and inattention to quantify impairment.

    Measured: Initial Visit, First follow up, Second follow up

  8. Fatigue Severity Scale (FSS)

    The Fatigue Severity Scale (FSS) measures the impact of fatigue on daily functioning and quality of life, assessing both the severity and the effect of fatigue on physical and cognitive activities through a self-reported questionnaire.

    Measured: Initial Visit, First follow up, Second follow up

  9. Fugl-Meyer Sensory Assessment: Touch and Proprioception

    The Fugl-Meyer Sensory Assessment evaluates sensory function in stroke patients by assessing light touch sensitivity and joint position sense (proprioception) in the affected limbs.

    Measured: Initial Visit, First follow up, Second follow up

  10. Kinect: Sensor-based Upper Extremity Reachable Workspace Evaluation

    The Kinect workspace measures the three-dimensional reachable space of the upper limb in hemiplegic stroke patients by tracking movement using a Kinect sensor, providing an objective assessment of functional reaching ability.

    Lee, Y. M., Lee, S., Uhm, K. E., Kurillo, G., Han, J. J., \& Lee, J. (2020). Upper Limb Three-Dimensional Reachable Workspace Analysis Using the Kinect Sensor in Hemiplegic Stroke Patients: A Cross-Sectional Observational Study. American journal of physical medicine \& rehabilitation, 99(5), 397-403. https://doi.org/10.1097/PHM.0000000000001350

    Measured: Initial Visit, First follow up, Second follow up

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jun 2025
  2. Study start20 Aug 2025 (estimated)
  3. Primary completion31 Dec 2025 (estimated)
  4. Study completion29 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
32 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07042152
Sponsor's protocol ID
2621
Status last verified
Aug 2025
First submitted
19 May 2025
Last updated
19 Aug 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: We do not plan to share Individual Participant Data (IPD) with external researchers to ensure compliance with UCI's data management requirements, maintain participant confidentiality, and restrict access to approved UCI researchers using only deidentified data within our institution

Publications

  • Schwerz de Lucena D, Rowe JB, Okita S, Chan V, Cramer SC, Reinkensmeyer DJ. Providing Real-Time Wearable Feedback to Increase Hand Use after Stroke: A Randomized, Controlled Trial. Sensors (Basel). 2022 Sep 14;22(18):6938. doi: 10.3390/s22186938.

    PubMed 36146287

Questions about this trial

What is this clinical trial studying?

A study testing Smartwatch App for Movement Variability, Smartwatch App for Active Time and Motivational Interviewing (Within Subjects) in people with Chronic Stroke Patients, run by University of California, Irvine at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 19 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Vicky Chan, DPT (9498248423, vchan2@uci.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Variability Measurement (time frame: From enrollment to the end of treatment and follow up measurement (9 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07042152, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in